Evoluting Ultimaster

 

Deliver optimal results to every patient in your practice – no matter how complex the procedure. 

 

With a global clinical program with over 50,000 patients, covering the most complex sub-groups, Ultimaster™ represents proven efficacy and safety you can rely on. In addition, our bio-inspired design and advanced polymer technology reduces the risk of complications and improves outcomes.

 

A routine procedure could turn into a complex case at any point, so it’s essential to have a tool you can trust. Ultimaster™ assures that you will be prepared for what’s coming next.

 

ULTIMASTER™ DES FAMILY. READY. SET. ACTION.

 

Bifurcation/LMT

INNOVATIVE TECHNOLOGY

New 10-crown design in the large vessel to ensure better apposition even in large bifurcations, including left main trunk1,2,3

featured_ultimaster_innovative-technology_img_01.png

EDUCATION

Learning from bench testing : Stent performance after overexpansion using

Lecture of Euro Bifurcation Club 16th consensus document

Long/Diffuse Lesion

INNOVATIVE TECHNOLOGY

New 44 & 50m lengths, for optimal sizing in long lesions1,2

featured_ultimaster_innovative-technology_img_02.png

High Bleeding Risk (HBR)

INNOVATIVE TECHNOLOGY

Abluminal gradient bioresorbable coating

featured_ultimaster_innovative-technology_img_03.png

EDUCATION

MASTER DAPT results can only be attributed to the UltimasterTM stent.

featured_ultimaster_education_img_02.png

ITS RESULTS

MATER DAPT study result applies to the UltimasterTM DES Family.
UltimasterTM is the only stent with evidence showing that 1-month DAPT is safe and actually safer than a more prolonged regimen in high breeding risk patients.

Prof.Marco VALGIMIGLI

Reference